The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 309: Single Agent Phase 1 Clinical Trials" during the SITC 2019 Annual Meeting on November 9, 2019. Available here are the presentation slides and video from the session.
34th Annual Meeting Organizers
Session Co-Chairs
To view the entire program schedule (including presenter permission to post) please click here.
Meeting: SITC 34th Annual Meeting; Concurrent Session 309: Single Agent Phase 1 Clinical Trials; Presenter: Marjorie G. Zauderer, MD, MS, FACP – Memorial Sloan Kettering Cancer Center; Date: November 9, 201900:10:41
Meeting: SITC 34th Annual Meeting; Concurrent Session 309: Single Agent Phase 1 Clinical Trials; Presenter: Anthony W. Tolcher, MD, FRCPC – Next Oncology; Date: November 9, 201900:18:16
Meeting: SITC 34th Annual Meeting; Concurrent Session 309: Single Agent Phase 1 Clinical Trials; Presenter: Jacob Thomas, MD – USC Norris Comprehensive Cancer Center; Date: November 9, 201900:14:56
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us